Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by gregoooon Nov 25, 2013 9:11am
210 Views
Post# 21937453

Assets sold-now what?

Assets sold-now what?
-11-25 07:09 ET - News Release

 

Mr. Ron MacMicken reports

SANTA MARIA PETROLEUM INC. DISPOSES OF ITS PARTICIPATION INTEREST IN THE INVESTMENTS, INCOME AND REVENUES OF THE LLANOS 27 PROJECT IN THE LLANOS BASIN IN COLOMBIA

On Nov. 21, 2013, Santa Maria Petroleum Inc. entered into a share purchase agreement with Global Oil & Gas Services Ltd., a company incorporated pursuant to the laws of Dubai, United Arab Emirates, by which Global will acquire all of the shares of a newly incorporated wholly owned subsidiary of Santa Maria (Newco). Through a reorganization to be completed by Dec. 18, 2013, Santa Maria shall transfer to Newco the assets and liabilities of its Colombian branch, including its participation interest in the investments, income and revenues of the Llanos 27 project in the Los Llanos basin in Colombia, subject to a working capital adjustment. Under the working capital adjustment, Newco will have a cash balance of $450,000 (U.S.), and all amounts receivable, including refundable value-added-tax and income tax amounts, will be paid to Santa Maria. Santa Maria will pay all outstanding trade liabilities incurred to the closing date.

Under the share purchase agreement, Global shall replace the $1.85-million (U.S.) letter of credit that had been provided by Santa Maria to the Agencia Nacional de Hidrocarburos in order to guarantee the operator's work commitments on this project. This letter of credit is currently secured by a guaranteed investment certificate. When the letter of credit is released and the working capital requirement is financed, the remaining funds, approximately $1.4-million, will be transferred to the company's general cash balances.

The foregoing transaction constitutes a sale of all or substantially all of the property and assets of the company. The share purchase agreement is subject to various conditions, including, but not limited to, receiving the approval of the company's shareholders and the TSX Venture Exchange. Notice of a special shareholder meeting will be made in due course.

Following the sale of Newco and the effective transfer of its interest in the project, Santa Maria will have disposed of all its interests in Colombia and will have no further work commitments or financial obligations arising from its former interests in Colombia. Management will assess the options for the company upon closing of the Global transaction.

Bullboard Posts